| abstract |
A malignant glioma target peptide, a nucleic acid encoding the peptide, a carrier molecule for delivery of malignant glioma containing the peptide, a complex containing the peptide, and a pharmaceutical composition containing the complex, And a diagnostic imaging agent comprising the peptide. A peptide comprising an amino acid sequence represented by NTGSPYE or RGATPMS, or an amino acid sequence in which one or two amino acids are deleted, substituted, inserted and / or added in the amino acid sequence, and the brain From a peptide having a transition activity and an action to be selectively taken up by malignant glioma cells, or an amino acid sequence in which one or two arbitrary amino acids are added to the C-terminal side and / or the N-terminal side of the peptide And a peptide having a brain-transition activity and an action of being selectively taken up by malignant glioma cells. [Selection figure] None |